Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy

Spinal muscular atrophy (SMA), characterized by specific degeneration of spinal motor neurons, is caused by mutations in the survival of motor neuron 1, telomeric (SMN1) gene and subsequent decreased levels of functional SMN. How the deficiency of SMN, a ubiquitously expressed protein, leads to spin...

Full description

Bibliographic Details
Main Authors: Chong-Chong Xu, Kyle R. Denton, Zhi-Bo Wang, Xiaoqing Zhang, Xue-Jun Li
Format: Article
Language:English
Published: The Company of Biologists 2016-01-01
Series:Disease Models & Mechanisms
Subjects:
Online Access:http://dmm.biologists.org/content/9/1/39
_version_ 1818368421704761344
author Chong-Chong Xu
Kyle R. Denton
Zhi-Bo Wang
Xiaoqing Zhang
Xue-Jun Li
author_facet Chong-Chong Xu
Kyle R. Denton
Zhi-Bo Wang
Xiaoqing Zhang
Xue-Jun Li
author_sort Chong-Chong Xu
collection DOAJ
description Spinal muscular atrophy (SMA), characterized by specific degeneration of spinal motor neurons, is caused by mutations in the survival of motor neuron 1, telomeric (SMN1) gene and subsequent decreased levels of functional SMN. How the deficiency of SMN, a ubiquitously expressed protein, leads to spinal motor neuron-specific degeneration in individuals affected by SMA remains unknown. In this study, we examined the role of SMN in mitochondrial axonal transport and morphology in human motor neurons by generating SMA type 1 patient-specific induced pluripotent stem cells (iPSCs) and differentiating these cells into spinal motor neurons. The initial specification of spinal motor neurons was not affected, but these SMA spinal motor neurons specifically degenerated following long-term culture. Moreover, at an early stage in SMA spinal motor neurons, but not in SMA forebrain neurons, the number of mitochondria, mitochondrial area and mitochondrial transport were significantly reduced in axons. Knocking down of SMN expression led to similar mitochondrial defects in spinal motor neurons derived from human embryonic stem cells, confirming that SMN deficiency results in impaired mitochondrial dynamics. Finally, the application of N-acetylcysteine (NAC) mitigated the impairment in mitochondrial transport and morphology and rescued motor neuron degeneration in SMA long-term cultures. Furthermore, NAC ameliorated the reduction in mitochondrial membrane potential in SMA spinal motor neurons, suggesting that NAC might rescue apoptosis and motor neuron degeneration by improving mitochondrial health. Overall, our data demonstrate that SMN deficiency results in abnormal mitochondrial transport and morphology and a subsequent reduction in mitochondrial health, which are implicated in the specific degeneration of spinal motor neurons in SMA.
first_indexed 2024-12-13T23:07:41Z
format Article
id doaj.art-0abfd2d1f5d04bbd80886802d514dac5
institution Directory Open Access Journal
issn 1754-8411
1754-8403
language English
last_indexed 2024-12-13T23:07:41Z
publishDate 2016-01-01
publisher The Company of Biologists
record_format Article
series Disease Models & Mechanisms
spelling doaj.art-0abfd2d1f5d04bbd80886802d514dac52022-12-21T23:28:14ZengThe Company of BiologistsDisease Models & Mechanisms1754-84111754-84032016-01-0191394910.1242/dmm.021766021766Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophyChong-Chong Xu0Kyle R. Denton1Zhi-Bo Wang2Xiaoqing Zhang3Xue-Jun Li4 Department of Neuroscience, University of Connecticut Health Center, Farmington, CT 06030, USA Department of Neuroscience, University of Connecticut Health Center, Farmington, CT 06030, USA Department of Neuroscience, University of Connecticut Health Center, Farmington, CT 06030, USA Department of Regenerative Medicine, Tongji University School of Medicine, Shanghai 200092, China Department of Neuroscience, University of Connecticut Health Center, Farmington, CT 06030, USA Spinal muscular atrophy (SMA), characterized by specific degeneration of spinal motor neurons, is caused by mutations in the survival of motor neuron 1, telomeric (SMN1) gene and subsequent decreased levels of functional SMN. How the deficiency of SMN, a ubiquitously expressed protein, leads to spinal motor neuron-specific degeneration in individuals affected by SMA remains unknown. In this study, we examined the role of SMN in mitochondrial axonal transport and morphology in human motor neurons by generating SMA type 1 patient-specific induced pluripotent stem cells (iPSCs) and differentiating these cells into spinal motor neurons. The initial specification of spinal motor neurons was not affected, but these SMA spinal motor neurons specifically degenerated following long-term culture. Moreover, at an early stage in SMA spinal motor neurons, but not in SMA forebrain neurons, the number of mitochondria, mitochondrial area and mitochondrial transport were significantly reduced in axons. Knocking down of SMN expression led to similar mitochondrial defects in spinal motor neurons derived from human embryonic stem cells, confirming that SMN deficiency results in impaired mitochondrial dynamics. Finally, the application of N-acetylcysteine (NAC) mitigated the impairment in mitochondrial transport and morphology and rescued motor neuron degeneration in SMA long-term cultures. Furthermore, NAC ameliorated the reduction in mitochondrial membrane potential in SMA spinal motor neurons, suggesting that NAC might rescue apoptosis and motor neuron degeneration by improving mitochondrial health. Overall, our data demonstrate that SMN deficiency results in abnormal mitochondrial transport and morphology and a subsequent reduction in mitochondrial health, which are implicated in the specific degeneration of spinal motor neurons in SMA.http://dmm.biologists.org/content/9/1/39Induced pluripotent stem cellsiPSCsHuman embryonic stem cellshESCsSpinal muscular atrophyMitochondrial transport and morphology
spellingShingle Chong-Chong Xu
Kyle R. Denton
Zhi-Bo Wang
Xiaoqing Zhang
Xue-Jun Li
Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy
Disease Models & Mechanisms
Induced pluripotent stem cells
iPSCs
Human embryonic stem cells
hESCs
Spinal muscular atrophy
Mitochondrial transport and morphology
title Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy
title_full Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy
title_fullStr Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy
title_full_unstemmed Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy
title_short Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy
title_sort abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy
topic Induced pluripotent stem cells
iPSCs
Human embryonic stem cells
hESCs
Spinal muscular atrophy
Mitochondrial transport and morphology
url http://dmm.biologists.org/content/9/1/39
work_keys_str_mv AT chongchongxu abnormalmitochondrialtransportandmorphologyasearlypathologicalchangesinhumanmodelsofspinalmuscularatrophy
AT kylerdenton abnormalmitochondrialtransportandmorphologyasearlypathologicalchangesinhumanmodelsofspinalmuscularatrophy
AT zhibowang abnormalmitochondrialtransportandmorphologyasearlypathologicalchangesinhumanmodelsofspinalmuscularatrophy
AT xiaoqingzhang abnormalmitochondrialtransportandmorphologyasearlypathologicalchangesinhumanmodelsofspinalmuscularatrophy
AT xuejunli abnormalmitochondrialtransportandmorphologyasearlypathologicalchangesinhumanmodelsofspinalmuscularatrophy